5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide

C59H54F9N27Pt3 — CID 162214196

IUPAC5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide
SMILESCC(C)n1ccnc1-c1cc(C(F)(F)F)n[n-]1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2C(C)C)n1.Cc1n[n-]c(-c2nccn2C)n1.Cn1ccnc1-c1cc(C(F)(F)F)n[n-]1.FC(F)(F)c1cc(-c2nccn2-c2ccccc2)[n-]n1.[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C13H8F3N4.C12H10N5.C10H10F3N4.C9H12N5.C8H6F3N4.C7H8N5.3Pt/c14-13(15,16)11-8-10(18-19-11)12-17-6-7-20(12)9-4-2-1-3-5-9;1-9-14-11(16-15-9)12-13-7-8-17(12)10-5-3-2-4-6-10;1-6(2)17-4-3-14-9(17)7-5-8(16-15-7)10(11,12)13;1-6(2)14-5-4-10-9(14)8-11-7(3)12-13-8;1-15-3-2-12-7(15)5-4-6(14-13-5)8(9,10)11;1-5-9-6(11-10-5)7-8-3-4-12(7)2;;;/h1-8H;2-8H,1H3;3-6H,1-2H3;4-6H,1-3H3;2-4H,1H3;3-4H,1-2H3;;;/q6*-1;3*+2
InChIKeyZTGDWYJTHXDIJW-UHFFFAOYSA-N
MW1897.49 g/mol
LogP9.79
Rot. Bonds10

About 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide

5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide (PubChem CID 162214196) has the molecular formula C59H54F9N27Pt3 and a molecular weight of 1897.49 g/mol. Its IUPAC name is 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide.

Molecular Properties

Compound Name5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide
PubChem CID162214196
Molecular FormulaC59H54F9N27Pt3
Molecular Weight1897.49 g/mol
Exact Mass1896.39
IUPAC Name5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide
SMILESCC(C)n1ccnc1-c1cc(C(F)(F)F)n[n-]1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2C(C)C)n1.Cc1n[n-]c(-c2nccn2C)n1.Cn1ccnc1-c1cc(C(F)(F)F)n[n-]1.FC(F)(F)c1cc(-c2nccn2-c2ccccc2)[n-]n1.[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C13H8F3N4.C12H10N5.C10H10F3N4.C9H12N5.C8H6F3N4.C7H8N5.3Pt/c14-13(15,16)11-8-10(18-19-11)12-17-6-7-20(12)9-4-2-1-3-5-9;1-9-14-11(16-15-9)12-13-7-8-17(12)10-5-3-2-4-6-10;1-6(2)17-4-3-14-9(17)7-5-8(16-15-7)10(11,12)13;1-6(2)14-5-4-10-9(14)8-11-7(3)12-13-8;1-15-3-2-12-7(15)5-4-6(14-13-5)8(9,10)11;1-5-9-6(11-10-5)7-8-3-4-12(7)2;;;/h1-8H;2-8H,1H3;3-6H,1-2H3;4-6H,1-3H3;2-4H,1H3;3-4H,1-2H3;;;/q6*-1;3*+2
InChIKeyZTGDWYJTHXDIJW-UHFFFAOYSA-N
XLogP9.79
TPSA307.53 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds10
Heavy Atoms98
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001897.49
LogP ≤ 59.79
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Analyze 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Ethyl acetate;bis(3-(1-phenylimidazol-2-yl)-5-(trifluoromethyl)pyrazol-1-ide);platinum(2+)
CID 168346598
Platinum(2+);bis(3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)pyrazol-1-ide)
CID 168346599
Platinum(2+);3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)pyrazol-1-ide;2-[5-(trifluoromethyl)pyrazol-1-id-3-yl]pyridine
CID 168346600
Diphenyltetraazaporphyrin
CID 132426902
2-(2,4-Difluorobenzene-6-id-1-yl)pyridine;iridium;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide
CID 57668487
bis(1-(2,4-difluorobenzene-6-id-1-yl)-3-methyl-2H-benzimidazol-3-ium-2-ide);iridium;2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 57738240
bis(4,5-dimethyl-1-phenyl-3-phenyl-2H-imidazol-1-ium-2-ide);iridium;2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 57738246
bis(1-(2,4-difluorobenzene-6-id-1-yl)-3-(2,4-difluorophenyl)-4,5-dimethyl-2H-imidazol-3-ium-2-ide);iridium;2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 57738558
3-(1,1-Difluoroethyl)-4-phenyl-5-phenyl-1,2,4-triazole;iridium;2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58426438
Iridium;4-phenyl-3-phenyl-5-(1,1,2,2-tetrafluoropropyl)-1,2,4-triazole;2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58426452
3-(1,1-Difluoropentyl)-4-phenyl-5-phenyl-1,2,4-triazole;iridium;2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine
CID 58426468
5-(1-Phenylimidazol-4-yl)-3-(trifluoromethyl)pyrazol-1-ide;ZINC
CID 58858984

Frequently Asked Questions

What is the IUPAC name of 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide?
The IUPAC name of 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide (CID 162214196) is 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide.
What is the SMILES notation for 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide?
The canonical SMILES for 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide is CC(C)n1ccnc1-c1cc(C(F)(F)F)n[n-]1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2C(C)C)n1.Cc1n[n-]c(-c2nccn2C)n1.Cn1ccnc1-c1cc(C(F)(F)F)n[n-]1.FC(F)(F)c1cc(-c2nccn2-c2ccccc2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide?
The InChIKey is ZTGDWYJTHXDIJW-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H8F3N4.C12H10N5.C10H10F3N4.C9H12N5.C8H6F3N4.C7H8N5.3Pt/c14-13(15,16)11-8-10(18-19-11)12-17-6-7-20(12)9-4-2-1-3-5-9;1-9-14-11(16-15-9)12-13-7-8-17(12)10-5-3-2-4-6-10;1-6(2)17-4-3-14-9(17)7-5-8(16-15-7)10(11,12)13;1-6(2)14-5-4-10-9(14)8-11-7(3)12-13-8;1-15-3-2-12-7(15)5-4-6(14-13-5)8(9,10)11;1-5-9-6(11-10-5)7-8-3-4-12(7)2;;;/h1-8H;2-8H,1H3;3-6H,1-2H3;4-6H,1-3H3;2-4H,1H3;3-4H,1-2H3;;;/q6*-1;3*+2.
What are the key properties of 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide?
5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide has a molecular weight of 1897.49 g/mol, XLogP of 9.79, 10 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(1-methylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tris(platinum(2+));5-(1-propan-2-ylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide is sourced from PubChem (CID 162214196), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).